Summary
This 8-K filing from CVS Health Corporation announces a significant leadership transition. Larry J. Merlo, President and CEO, will retire effective May 31, 2021, stepping down from his CEO role on February 1, 2021, after a 40-year career with the company. He will remain employed to assist with the transition. Mr. Merlo will not seek re-election to the Board of Directors. In conjunction with this announcement, the Board has appointed Karen S. Lynch as the new President and Chief Executive Officer, effective February 1, 2021, and also as a member of the Board of Directors. Ms. Lynch, currently Executive Vice President and President of Aetna, brings extensive experience from within CVS Health. The filing also details Ms. Lynch's new employment agreement, including her base salary, bonus potential, equity awards, and severance provisions.
Key Highlights
- 1Larry J. Merlo to retire as President and CEO, stepping down from CEO role on February 1, 2021, and retiring fully on May 31, 2021.
- 2Karen S. Lynch appointed as the new President and Chief Executive Officer, effective February 1, 2021.
- 3Ms. Lynch will also join the Board of Directors upon her appointment as CEO.
- 4Mr. Merlo's retirement is amicable and follows a 40-year tenure with CVS Health.
- 5Ms. Lynch's employment agreement includes an annual base salary of $1.45 million.
- 6Ms. Lynch will have a target annual bonus opportunity of 200% of her base salary.
- 7Ms. Lynch's target annual equity compensation for 2021 is set at $11,000,000.